De-cancer / curatio / medicinae / esophageal

Medicamenta ad esophageal cancer Approbata

Haec pagina lists cancer medicinae probatus fuerit per Quod Cibus et medicamentis Administration (FDA) et esophageal cancer, cancer inter coniunctas gastroesophageal. Album quod includit nomina generica et torris nomen. Quod pharmacum est scriptor nomina NCI ad cancer summaria medicamentis Information. Medicinae non sit in esophageal cancer, quae non enumerantur hic.

Medicamenta ad esophageal cancer Approbata

Keytruda (Pembrolizumab)

Pembrolizumab

Pulchra medicamento expensis esophageal cancer

Fu-XLVI

XELIRI

Medicamenta Approbata pro Cancro Gastroesophageal adiunctae

Cyramza (Ramucirumab)

Docetaxel

Herceptin (trastuzumab)

Keytruda (Pembrolizumab)

Lonsurf (Trifluridine et Tipiracil Hydrochloride)

Pembrolizumab

Ramucirumab

Taxotere (Docetaxel)

trastuzumab

Et Trifluridine Tipiracil Hydrochloride